Literature DB >> 19195690

Invasive hydatidiform mole: immunohistochemical labelling of inhibin/activin subunits, Ki67, p53 and glycodelin A in a rare case.

Josef Makovitzky1, Anngret Radtke, Naim Shabani, Klaus Friese, Bernd Gerber, Ioannis Mylonas.   

Abstract

Invasive trophoblastic mole is an extremely rare condition. Its early recognition is essential since it can transform into an invasive type of tumour. Immunohistochemistry was performed with monoclonal antibodies against inhibin-alpha, -betaA and -betaB, Ki67, p53 and glycodelin A in a rare case of accidentally diagnosed invasive trophoblastic mole. There was labelling of the inhibin/activin subunits, Ki67 and p53, while glycodelin A showed minimal immunopositivity. Therefore, since the pathological diagnosis of an invasive mole is difficult, the immunohistochemical detection of inhibin/activin subunits, Ki67, p53 and glycodelin A might be additional useful tumour markers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19195690     DOI: 10.1016/j.acthis.2008.11.019

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  3 in total

1.  Inhibin/activin-betaE subunit in normal and malignant human cervical tissue and cervical cancer cell lines.

Authors:  Florian Bergauer; Ansgar Brüning; Naim Shabani; Thomas Blankenstein; Julia Jückstock; Darius Dian; Ioannis Mylonas
Journal:  J Mol Histol       Date:  2009-12-24       Impact factor: 2.611

2.  An invasive mole with pulmonary metastases in a 55-year-old postmenopausal Syrian woman: a case report and review of the literature.

Authors:  Sawsan Ismail; Karen Mikhael; Nehad Salloum; Zuheir Alshehabi
Journal:  J Med Case Rep       Date:  2021-01-18

3.  Siglec-6 is expressed in gestational trophoblastic disease and affects proliferation, apoptosis and invasion.

Authors:  Kristen K Rumer; Miriam D Post; Rhea S Larivee; Martina Zink; Jill Uyenishi; Anita Kramer; Deanna Teoh; Kevin Bogart; Virginia D Winn
Journal:  Endocr Relat Cancer       Date:  2012-11-19       Impact factor: 5.678

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.